MARKET

AGTC

AGTC

AGTC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.63
0.00
0.00%
Closed 16:41 07/14 EDT
OPEN
5.61
PREV CLOSE
5.63
HIGH
5.71
LOW
5.33
VOLUME
231.23K
TURNOVER
--
52 WEEK HIGH
10.42
52 WEEK LOW
2.290
MARKET CAP
145.06M
P/E (TTM)
-2.5714
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AGTC stock price target is 15.44 with a high estimate of 25.00 and a low estimate of 7.50.

EPS

AGTC News

More
Should You Buy Applied Genetic Technologies Corp (AGTC)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 07/08 01:11
Applied Genetic Tech up 9% on potential takeover interest
Seeking Alpha - Article · 07/01 17:08
Here's Why Applied Genetic Technologies (AGTC) is a Great Momentum Stock to Buy
Does Applied Genetic Technologies (AGTC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks · 06/26 16:00
Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year?
Is (AGTC) Outperforming Other Medical Stocks This Year?
Zacks · 06/26 15:30
Applied Genetic (AGTC) Soars: Stock Adds 6.1% in Session
Zacks · 06/24 13:40
AGTC Set To Join Russell 3000 And 2000 Indexes
Benzinga · 06/24 11:15
AGTC Set to Join Russell 3000® and 2000® Indexes
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 24, 2020 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
GlobeNewswire · 06/24 11:00
Edited Transcript of AGTC.OQ earnings conference call or presentation 13-May-20 12:00pm GMT
Q3 2020 Applied Genetic Technologies Corp Earnings Call
Thomson Reuters StreetEvents · 06/23 20:05

Industry

Biotechnology & Medical Research
+2.63%
Pharmaceuticals & Medical Research
+1.70%

Hot Stocks

Symbol
Price
%Change

About AGTC

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).
More

Webull offers kinds of Applied Genetic Technologies Corp stock information, including NASDAQ:AGTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGTC stock methods without spending real money on the virtual paper trading platform.